Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Eric I. Felner"'
Autor:
Chao‐Yi Lu, Pankaj Rohilla, Eric I. Felner, Gaurav Byagathvalli, Erkan Azizoglu, M. Saad Bhamla, Mark R. Prausnitz
Publikováno v:
Bioengineering & Translational Medicine, Vol 9, Iss 4, Pp n/a-n/a (2024)
Abstract Electroporation, or the use of electric pulses to facilitate the intracellular delivery of DNA, RNA, and other molecules, is a well‐established technique, that has been demonstrated to significantly augment the immunogenicity of DNA/mRNA v
Externí odkaz:
https://doaj.org/article/ea6de8f0afe94118a8c80efb83b15e79
Autor:
Sarah Gold, BA, Christina Huang, BS, Rakan Radi, MD, Pranav Gupta, MBBS, Eric I. Felner, MD, MS, Jeehea Sonya Haw, MD, Krista Childress, MD, Nancy Sokkary, MD, Vin Tangpricha, MD, PhD, Michael Goodman, MD, MPH, Howa Yeung, MD, MSc
Publikováno v:
International Journal of Women's Dermatology, Vol 9, Iss 3, p e106 (2023)
Background:. Differences of sex development (DSD or disorders of sex development) are uncommon congenital conditions, characterized by atypical development of chromosomal, gonadal, or anatomic sex. Objective:. Dermatologic care is an important compon
Externí odkaz:
https://doaj.org/article/fd123ebd3e3747e6adb3b34a5fdb9ac9
Autor:
Andrey Romanyuk, Ruixue Wang, Alexander Marin, Benjamin M. Janus, Eric I. Felner, Dengning Xia, Yenny Goez-Gazi, Kendra J. Alfson, Abdul S. Yunus, Eric A. Toth, Gilad Ofek, Ricardo Carrion, Mark R. Prausnitz, Thomas R. Fuerst, Alexander K. Andrianov
Publikováno v:
Journal of Functional Biomaterials, Vol 14, Iss 1, p 16 (2022)
Ebolavirus (EBOV) infection in humans is a severe and often fatal disease, which demands effective interventional strategies for its prevention and treatment. The available vaccines, which are authorized under exceptional circumstances, use viral vec
Externí odkaz:
https://doaj.org/article/a885540978ff4542aea23a7fac2aa739
Autor:
Lining Ju, James D. McFadyen, Saheb Al-Daher, Imala Alwis, Yunfeng Chen, Lotte L. Tønnesen, Sophie Maiocchi, Brianna Coulter, Anna C. Calkin, Eric I. Felner, Neale Cohen, Yuping Yuan, Simone M. Schoenwaelder, Mark E. Cooper, Cheng Zhu, Shaun P. Jackson
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-16 (2018)
Diabetes is associated with an increased thrombotic response, but the mechanism is unknown. Here the authors demonstrate that compressive force activates integrin αIIbβ3 on discoid diabetic platelets and that platelet aggregates can be eliminated b
Externí odkaz:
https://doaj.org/article/39fb3cca5ca9489ba78bd4ef5db73aba
Publikováno v:
Diabetic medicine : a journal of the British Diabetic Association.
To compare the stress level in parents of children with new-onset type 1 diabetes receiving a fixed insulin dose for a fixed range of carbohydrates (CHOs) to parents of children receiving a precise insulin dose for a precise number of CHOs using an i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71b1ee83220bb44639b7209b863ba530
https://pubmed.ncbi.nlm.nih.gov/36617389
https://pubmed.ncbi.nlm.nih.gov/36617389
Publikováno v:
Diabetes. 70
Over the past 20 years, advances in diabetes technology and along with carbohydrate counting (CC) to determine insulin dose, has provided an opportunity for improvement in glycemic control and quality of life for children and adolescents with type 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6f76290c33a1c6f60d0e0d085a05606
https://doi.org/10.2337/db21-937-p
https://doi.org/10.2337/db21-937-p
Publikováno v:
Journal of clinical lipidology. 15(6)
We report a 13-year-old female with rapid-onset obesity, hypothalamic dysfunction, hypoventilation, and autonomic dysregulation (ROHHAD) syndrome, panhypopituitarism, dyslipidemia, type 2 diabetes mellitus, and nonalcoholic fatty liver disease, who d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5a1ddffd2bc8491cc7e7d85ba88bc78
https://pubmed.ncbi.nlm.nih.gov/34600840
https://pubmed.ncbi.nlm.nih.gov/34600840
Autor:
Stephen E Gitelman, Brian N Bundy, Ele Ferrannini, Noha Lim, J Lori Blanchfield, Linda A DiMeglio, Eric I Felner, Jason L Gaglia, Peter A Gottlieb, S Alice Long, Andrea Mari, Raghavendra G Mirmira, Philip Raskin, Srinath Sanda, Eva Tsalikian, John M Wentworth, Steven M Willi, Jeffrey P Krischer, Jeffrey A Bluestone, Mayalin Barr, Jeanne Buchanan, Joanne Cabbage, Peter Coleman, Monica De La Vega, Carmella Evans-Molina, Christine Ferrara, Felicity Healy, Laurie Higgins, Megan Hildinger, Margaret Jenkins, Nora Kayton Bryant, Amanda Kinderman, Nisha Koshy, Brianne Kost, Suzanne Krishfield, Olena Kucheruk, Karen Lindsley, Manasa Mantravadi, Shelley Mesfin, Aaron Michels, Mary Ellen Migre, Pantea Minnock, Elham Mohammed-Nur, Jennifer Nelson, Ashvin Nursing, Ryan O'Donnell, Diana Olivos, Melissa Parker, Leanne Redl, Nicole Reed, Brittany Resnick, Peter Sayre, Elisavet Serti, Emily Sims, Karen Smith, Carol Soppe, Fiona Stuart, Sarah Szubowicz, Michel Tansey, Jennifer Terrell, Sarah Tersey, Christine Torok, Kelly Watson, Rebecca Wesch, Steven Willi, Stephanie Woerner
Publikováno v:
Lancet Diabetes Endocrinol
Type 1 diabetes results from autoimmune-mediated destruction of β cells. The tyrosine kinase inhibitor imatinib might affect relevant immunological and metabolic pathways, and preclinical studies show that it reverses and prevents diabetes. Our aim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcc88b8333d4324e0044265eff7356ed
https://pubmed.ncbi.nlm.nih.gov/34214480
https://pubmed.ncbi.nlm.nih.gov/34214480
Autor:
Eva Tsalikian, Andrea Mari, Jeffrey A. Bluestone, Srinath Sanda, Peter A. Gottlieb, Steven M. Willi, Philip Raskin, S. Alice Long, Ele Ferrannini, Noha Lim, Jason L. Gaglia, John M. Wentworth, Linda A. DiMeglio, Jeffrey P. Krischer, Gleevec Study Team, Eric I. Felner, Stephen E. Gitelman, Raghavendra G. Mirmira, J Lori Blanchfield, Brian N. Bundy
Publikováno v:
SSRN Electronic Journal.
Background: Type 1 diabetes results from autoimmune-mediated destruction of beta cells. The tyrosine kinase inhibitor imatinib may impact relevant immunologic and metabolic pathways, and preclinical studies show that it reverses and prevents diabetes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0cbcbbc4adabd32b1b02c235995f21c8
https://doi.org/10.2139/ssrn.3773520
https://doi.org/10.2139/ssrn.3773520
Autor:
Eric I. Felner, Andrea K. Steck, Michael J. Haller, Yichuan Xia, Ramineh Zoka, Joseph A Hedrick, Jocelyn H. Leu, T Ger Study Investigators, Yinglei Li, Mark R. Rigby, Teresa Quattrin, Frank Vercruysse
Publikováno v:
N Engl J Med
Type 1 diabetes is an autoimmune disease characterized by progressive loss of pancreatic beta cells. Golimumab is a human monoclonal antibody specific for tumor necrosis factorIn this phase 2, multicenter, placebo-controlled, double-blind, parallel-g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::348dd322d47360729504372f1284867a
https://pubmed.ncbi.nlm.nih.gov/33207099
https://pubmed.ncbi.nlm.nih.gov/33207099